PATENT CLAIM ANALYSIS

Application Number: 15866744
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "180000"]

Abstract:
The present invention aims to provide an eye drop for treating macular edema. The present invention provides an eye drop for treating macular edema, which contains difluprednate as an active ingredient. The eye drop can afford effects such as improvement of visual acuity and decreased foveal retinal thickness in macular edema.

Claim (Index 57):
The method of  claim 56 , wherein refractory macular edema is macular edema for which a sufficient effect is not achieved by one or more of the treatments selected from the group consisting of photocoagulation by irradiation, vitreous surgery, systemic administration of steroid, intravitreal administration of a drug, and sub-Tenon administration of a drug.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.52778
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14661295', '13940370', '15471506', '11695527', '14972560']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8028425558565546
- 35 USC 102 Novelty (BERT): 0.6412468687973168
- Combined Prediction Score: 0.7866829871506309
- Mean Citation Score: 323.74317600000006
- Max Citation Score: 652.79486
- Similarity Product: 561.8613215402485

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test